About Medsensio
Medsensio is a company based in Tromsø (Norway) founded in 2017 by Lars Bongo, Johan Rav, and Anna Dranovska. Medsensio offers products and services including Virtual Clinic, Mobile App, Smart Care, Lung and Heart AI, and EHR Integration. Medsensio operates in a competitive market with competitors including Docturnal, RESPINOR, Ibrum Technologies, ResApp Health and Tambua Health, among others.
- Headquarter Tromsø, Norway
- Founders Lars Bongo, Johan Rav, Anna Dranovska
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medsensio As
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$81.29 K (USD), Grant
Jun 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medsensio
Medsensio offers a comprehensive portfolio of products and services, including Virtual Clinic, Mobile App, Smart Care, Lung and Heart AI, and EHR Integration.
Enables remote patient examinations and consultations for efficient healthcare.
Facilitates self-examinations and symptom reporting for patients at home.
Automates predefined responses to prevent unnecessary hospitalizations.
Detects abnormal sounds for early disease identification in patients.
Secures and manages patient health records for healthcare providers.
Funding Insights of Medsensio
Investors in Medsensio
Medsensio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Norinnova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ideas are developed into innovative solutions for society by Norinnova.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Medsensio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medsensio
Investment portfolio details for Medsensio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medsensio
Detailed financials for Medsensio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medsensio Comparisons
Peer comparison for Medsensio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medsensio
Medsensio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Docturnal, RESPINOR, Ibrum Technologies, ResApp Health and Tambua Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive solutions for tuberculosis detection and diagnostics are provided.
|
|
| Locked | Locked | Locked |
Real-time diaphragm monitoring devices are provided for medical decision making.
|
|
| Locked | Locked | Locked |
Devices for detecting undiagnosed cardiac and respiratory diseases are developed.
|
|
| Locked | Locked | Locked |
Respiratory diseases are diagnosed digitally from cough and breathing sounds.
|
|
| Locked | Locked | Locked |
Software for sound based cardiopulmonary disease diagnosis
|
Detailed competitors of Medsensio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medsensio
Complete news archive for Medsensio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medsensio
Medsensio was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Medsensio is headquartered in Tromsø, Norway. It is registered at Tromsø, Troms Og Finnmark, Norway.
Johan Rav is the current CEO of Medsensio. They have also founded this company.
Medsensio was founded in 2017 in Tromso, Norway, within the health technology sector. A platform has been developed to support respiratory diagnostics through deep learning tools for lung sound auscultation. Clinical insights on the respiratory system are provided to assist physicians in optimizing approaches for chronic conditions. Home care monitoring solutions are also offered to patients for ongoing respiratory health management.
Medsensio offers Virtual Clinic, Mobile App, Smart Care, Lung and Heart AI, and EHR Integration.
Medsensio has 2 investors. Key investors include European Union, and Norinnova.